ETFChannel.com
ICLR Description — Icon Plc

ICON provides outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations. Co. provides a range of clinical, consulting and commercial services ranging from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services. Co. focuses on development, management and analysis of programs that support clinical development process.

Company Name: 
Icon Plc
Website: 
www.iconplc.com
Sector: 
Biotechnology
Number of ETFs Holding ICLR: 
28
Total Market Value Held by ETFs: 
$389,624,938
Total Market Capitalization: 
$16,649,000,000
% of Market Cap. Held by ETFs: 
2.34%
 ETF   ICLR Weight   ICLR Amount 
 IWR   0.23%   $77,285,377         
 IWD   0.10%   $55,869,208         
 IWS   0.27%   $35,137,985         
 BBH   6.39%   $27,465,026         
 EIRL   20.75%   $24,248,785         
 FXH   1.63%   $20,588,526         
 IWB   0.05%   $18,763,885         
 SPDW   0.09%   $18,026,250         
 IWP   0.12%   $16,705,910         
 IYH   0.46%   $15,594,127         
List of all 28 ETFs holding ICLR »
Quotes delayed 20 minutes

Email EnvelopeFree ICLR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
89th percentile
(ranked higher than approx. 89% of all stocks covered)

Analysts Forecast:
ICLR Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding ICLR | Icon Plc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.